U.S. Hematology Diagnostics Market Size & Outlook, 2026-2033

Name: U.S. Hematology Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The hematology diagnostics market in the United States is expected to reach a projected revenue of US$ 3,527.4 million by 2033. A compound annual growth rate of 4.41% is expected of the United States hematology diagnostics market from 2026 to 2033.

Clinical Diagnostics
- In Vitro Diagnostics
  - Hematology Diagnostics Market Outlook

U.S. hematology diagnostics product outlook (Revenue, USD million, 2021-2033)
- Instruments
  - Hematology Analyzers
    - 3-Part Fully Automated Hematology Analyzers
    - 5-Part Fully Automated Hematology Analyzers
    - Semi-Automated Hematology Analyzers
  - Flow cytometers
  - Slide Stainers/Markers
- Consumables
  - Reagent
  - Stains
  - Controls and Calibrators
U.S. hematology diagnostics test type outlook (Revenue, USD million, 2021-2033)
- White Blood Cells (WBC) Test
- Red Blood Cells (RBC) Test
- Hemoglobin Test
- Hematocrit Test
- Platelet Function
U.S. hematology diagnostics end use outlook (Revenue, USD million, 2021-2033)
- Hospitals
- Diagnostic Labs
- Others

U.S. Hematology Diagnostics Market Size & Outlook, 2026-2033

Data Tree

Sign up - it's easy, and free!